A virus-specified polypeptide of 160000 mol. wt. (160K) was purified more than 1000-fold from the soluble proteins present in the culture medium of cells productively infected with herpesvirus saimiri (HVS). Purified preparations of the 160K polypeptide gave rise to high titre precipitating and neutralizing antibodies in immunized rabbits, which cross-neutralized independent isolates of HVS (neutralization rate constants, k, of between 3.8 and 4.8) and specifically precipitated the 160K polypeptide from extracts of cells infected with the homologous or heterologous strains of this virus. Antiserum to the 160K polypeptide of HVS also gave low (k = 0.02) levels of neutralization of the related herpesvirus ateles. Purified preparations of the 160K polypeptide were capable of removing most or all of the neutralizing antibody sera of squirrel monkeys with naturally acquired antibodies to HVS. The 160K polypeptide was previously shown to form part of the surface of enveloped virus particles. However, we show here that the 160K polypeptide is not extensively glycosylated in infected cells. The majority of glucosamine incorporation specific to HVS-infected cells was into eight regions with apparent mol. wt. of 170K to 220K, 125K to 145K, 115K to 120K, 83K to 88K, 65K to 75K, 52K to 58K, 25K to 27K and 12.5K to 13K. It remains possible that alternative cleaved or glycosylated forms of the 160K polypeptide are also present on the virus particle or that precipitating antibody to 160K and virus-neutralizing antibodies are not identical. However, our inability to detect precipitating antibody to virus-induced proteins or glycoproteins other than the 160K polypeptide and the high titre of neutralizing antibody present in this serum, provides reasonable evidence that it is the antibodies which react with the 160K polypeptide that are responsible for virus neutralization.
DanielM. D.,
SilvaD.,
JacksonD.,
SehgalP.,
BaggsR. B.,
HuntR. D.,
MelendezL. A.1976; Reactivation of squirrel monkey heart isolate (Herpesvirus saimiri strain) from latently infected human cell cultures and induction of malignant lymphoma in marmoset monkeys. In Comparative Leukemia Research pp 392–395 Bibliographa Haematologia, No, 43, Edited by
ClemmensonJ.,
YohnD. S.
Basel: S. Karger;
FalkL. A.,
NigidaS. M.,
DeinhardtF.,
WolfeL. G.,
CooperR. W.,
Hernandez camachoJ. L.1974; Herpesvirus ateles: properties of an oncogenic herpesvirus isolated from circulating lymphocytes of spider monkeys (ateles sp.). International Journal of Cancer 14:473–482
FleckensteinB.,
BornkammG. W.,
MulderC.,
WernerF. J.,
DanielM. D.,
FalkL. A.,
DeliusH.1978; Herpesvirus ateles DNA and its homology with herpesvirus saimiri nucleic acid. Journal of Virology 25:361–373
HeineJ. W.,
HonessR. W.,
CassaiE.,
RoizmanB.1974; Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. Journal of Virology 14:640–651
HoffmanG. J.,
JazarowitzS. C.,
HaywardS. D.1980; Monoclonal antibody against a 250, 000 dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proceedings of the National Academy of Sciences of the United States of America 77:2979–2983
HonessR. W.,
RoizmanB.1973; Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and non-structural herpesvirus polypeptides in the infected cell. Journal of Virology 12:1347–1365
HonessR. W.,
WatsonD. H.1974; Herpesvirus-specific polypeptides studied by polyacrylamide gel electrophoresis of immune precipitates. Journal of General Virology 22:171–185
HuntR. D.,
GarciaF. G.,
BarahonaH. H.,
KingN. W.,
FrazerC. E. O.,
MelendezL. V.1973; Spontaneous herpesvirus saimiri lymphoma in an owl monkey. Journal of Infectious Diseases 127:723–725
MelendezL. V.,
HuntR. D.,
KingN. W.,
BarahonaH. H.,
DanielM. D.,
FrazerC. E. O.,
GarciaF. G.1972; Herpesvirus ateles, a new lymphoma virus of monkeys. Nature New Biology 235:182–184
PowellK. L.,
BuchanA.,
SimC.,
WatsonD. H.1974; Type-specific protein in herpes simplex virus envelope reacts with neutralizing antibody. Nature, London 247:360–361
RandallR. E.,
HonessR. W.1980; Proteins of herpesvirus saimiri; identification of two virus polypeptides released into the culture medium of productively infected cells. Journal of General Virology 51:445–449
RandallR. E.,
KillingtonR. A.,
WatsonD. H.1980; Glycoproteins with type common and type specific antigenic sites excreted from cells infected with herpes simplex virus types 1 and 2. Journal of General Virology 48:297–310
SchafferP. A.,
FalkL. A.,
DeinhardtF.1975; Attenuation of herpesvirus saimiri for marmosets after successive passage in cell culture at 39 °C. Journal of the National Cancer Institute 55:1243–1246
SpearP. G.1976; Membrane proteins specified by herpes simplex virus. I. Identification of four glycoprotein precursors and their products in type 1 infected cells. Journal of Virology 17:991–1008
SpearP. G.,
RoizmanB.1972; Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. Journal of Virology 9:143–159
Thorley-LawsonD. A.,
GeilingerK.1980; Monoclonal antibodies against the major glycoprotein (gp 350/220) of Epstein-Barr virus neutralize infectivity. Proceedings of the National Academy of Sciences of the United States of America 77:5307–5311